Joseph Mitchell

Artiklar

Article: DRUG SAFETY. 2023;46(12):1335-1352
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.
Gauffin O; Brand JS; Vidlin SH; Sartori D; Asikainen S; Català M; Chalabi E; Dedman D; Danilovic A; Duarte-Salles T; García Morales MT; Hiltunen S; Jödicke AM; Lazarevic M; Mayer MA; Miladinovic J; Mitchell J; Pistillo A; Ramírez-Anguita JM; Reyes C; Rudolph A; Sandberg L; Savage R; Schuemie M; Spasic D; Trinh NTH; Veljkovic N; Vujovic A; de Wilde M; Zekarias A; Rijnbeek P; Ryan P; Prieto-Alhambra D; Norén GN
Article: VACCINE: X. 2021;9:100122
Appendicitis as a possible safety signal for the COVID-19 vaccines.
Mitchell J; Yue Q-Y
Article: SCIENTIFIC REPORTS. 2021;11(1):22599
Trends, relationships and case attribution of antibiotic resistance between children and environmental sources in rural India
Mitchell J; Purohit M; Jewell CP; Read JM; Marrone G; Diwan V; Lundborg CS

Review: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2022;13:20420986221118972
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge.
Rudolph A; Mitchell J; Barrett J; Sköld H; Taavola H; Erlanson N; Melgarejo-González C; Yue Q-Y